Yun Wang

7PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Nutrigenomics and personalised nutritionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 30, 2026
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.

|Aug 01, 2025
The bone marrow immune ecosystem shapes daratumumab acquired resistance in plasma cell myeloma.

Yun Wang, Shuzhao Chen, Zhijian Liang

|May 14, 2024
Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma.

Pei Guo, Yun Wang, Haiyan He

|Jun 30, 2023
Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials.

Yuanfang Li, Shuqiang Yuan, Yingbo Chen

|Nov 28, 2022
Prognostic value of the nutritional risk index in patients with newly diagnosed multiple myeloma.

Limei Zhang, Shuzhao Chen, Mayan Huang

|Jan 25, 2021
The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis.

Xiao-Jiang Chen, Shu-Qiang Yuan, Jin-Ling Duan

Pageof 2

Frequent Collaborators

2 joint publications

Runcong Nie

2 joint publications

Yuan-Fang Li

2 joint publications

Weida Wang

2 joint publications

Yang Liang